Hydroxychloroquine Sulfate (HCQ)

DRUG2 trials

Sponsors

Hackensack Meridian Health, Indiana University

Conditions

Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)Breast CancerCovid19Joint Pain

Phase 2

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

CompletedNCT04345653

Hackensack Meridian HealthCovid19

Start: 2020-04-14End: 2021-05-10Updated: 2021-05-12

Pilot Study of Hydroxychloroquine for the Treatment of AIMSS

Not yet recruitingNCT07825454

Indiana UniversityAromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Joint Pain

Start: 2026-09-01End: 2029-12-01Target: 35Updated: 2026-09-17